Webcast CS1 Phase IIa

Event

Event

Welcome to our webcast!

The webcast will start at 14:00 CET on March 4, 2025. Company executives will share the Phase IIa trial data of CS1 with a presentation followed by a Q&A session.

View the presentation (PDF) > 


Relevant materials

The webcast is held in connection with the press release announcement published on February 25, 2025, where additional data from the Phase IIa trial data of CS1 were shared showing encouraging signs of reverse vascular remodeling effects of CS1. Read the full announcement via the link below:

Cereno Scientific’s lead candidate CS1’s reverse vascular remodeling profile is accompanied by improvement of right-ventricular function in additional data from Phase IIa trial ­– webcast on March 4 >